Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

View:
Post by Bucknelly21 on Mar 13, 2023 10:54am

Paul

This guy has absolutely created a dumpster fire is his years at there, im sorry but you super large shareholders need to start throwing some weight around at agms
Comment by Kd5513 on Mar 13, 2023 11:03am
I just got a reply on my emails to the IR, nothing but a PR doc dump so no value there. However, I remember Paul making a comment about something on environment or something WOKE a while back and a few commenting, looking at the IR signature graphic it tells me all I need to know at this point. It appears that Paul's focus is DEI nonsense.......so go WOKE go BROKE, he's a prime example of ...more  
Comment by SPCEO1 on Mar 13, 2023 12:10pm
It is certainly understandable to be angry and demand the board get thrown out. But you have to have a plan that is better than what the current board is approving or any effort to throw the current board out of office is a waste of time. So, for those that want to make changes, what are those changes - what is your plan that is superior to the one already in place?  Now, I have the ...more  
Comment by Trogarzon on Mar 13, 2023 12:19pm
How about putting a strategic review plan to sell the company to the highest bidder.  How could that be done.  Collectively decide that this might just be the best way forward for shareholder value.  
Comment by SPCEO1 on Mar 13, 2023 12:31pm
I would not totally rule that option out but it seems unlikely to be the best way to maximize shareholder value given it would be a fire sale and not one based on strength. And exactly who is wanting to buy two small HIV drugs anyway. Probably only a financial buyer who wants to buy on the cheap and run the company for cash to get a return. So, this is likely not a great option other than for ...more  
Comment by Trogarzon on Mar 13, 2023 12:43pm
What king of price could such a buyer fetch in your book. 
Comment by SPCEO1 on Mar 13, 2023 1:16pm
If a finacial buyer were to emerge, they would be looking for a real bargain. Basically, they would exhange your ongoing agony regarding THTX for a low price where they would have a high probability of making a nice return under even bad assumptions about the future of THTX legacy drug sales. So, a price that most would find to be too low.
Comment by Trogarzon on Mar 13, 2023 1:49pm
You must be wright, you've been all along.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities